Literature DB >> 18358997

Metastatic ocular tumors of the anterior segment.

Jeff Miller1.   

Abstract

BACKGROUND: Breast cancer is a common neoplasm in women and is the most common cause of intraocular metastatic tumors. These tumors can arise weeks to years after the primary tumor of the breast and typically indicate a poor prognosis for the patient because of the disseminated nature of the disease. CASE REPORT: A 57-year-old woman with a history of breast cancer presented with a red, painful right eye and decreased vision in that eye. A large, amelanotic mass was seen in the anterior chamber. A diagnosis of metastatic intraocular tumor was made. The patient was referred to an ophthalmologist specializing in ocular oncology. Unfortunately, the patient died within 1 week.
CONCLUSION: Treatment of anterior-segment metastatic tumors is aimed at decreasing inflammation and intraocular pressure. A timely referral should be made to an onco-ophthalmologist and general oncologist for further treatment and systemic workup. The patient should be counseled on the severity and poor prognosis of his or her condition.

Entities:  

Mesh:

Year:  2008        PMID: 18358997     DOI: 10.1016/j.optm.2007.10.011

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  4 in total

1.  The CT appearance of a corneal melt: report of 2 cases.

Authors:  A Bluestone; J Ackert; P M Som
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-22       Impact factor: 3.825

Review 2.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

3.  Not just a red eye.

Authors:  Valerie Juniat; Nigel Andrew
Journal:  BMJ Case Rep       Date:  2014-04-03

4.  Iris metastasis as the first sign of small cell lung cancer: A case report.

Authors:  Shi-Liang Liu; Yu-Hong Nie; Tao He; Xi-Xi Yan; Yi-Qiao Xing
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.